Home / Brands / Dr. Reddy's Laboratories
Dr. Reddy's Laboratories Recalls
165 recalls on record · August 8, 2012 to December 17, 2025 · Drugs
Recalls by year
12
13
14
15
16
17
18
19
20
21
22
23
24
25
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
June 24, 2015DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Amlodipine besylate and Atorvastatin calcium tablets, 5mg/10mg, packaged in a)30-count bottle (NDC 43598-322-30), b) 90-
Hazard: Subpotent drug
June 24, 2015DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Divalproex Sodium Extended-Release Tablets, USP, 500 mg, 100 count bottles, Rx Only, Mfd. By. Dr. Reddy's Laboratories
Hazard: Failed Dissolution Specifications; exceeded specification at the 9 hour time point
June 24, 2015DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Divalproex Sodium Extended-Release Tablets, USP, (valproic acid activity), 250 mg, 100 count (NDC 55111-533-01) and 500
Hazard: Failed Dissolution Specifications; exceeded specification at the 9 hour time point
June 18, 2014DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Dr. Reddy's Metoprolol Succinate Extended Release Tablets, USP 25 mg. 100-count bottle, Rx only, Manufactured By: Dr. R
Hazard: Failed Dissolution Specifications: Failure of dissolution test observed at the 18 month time point.
March 12, 2014DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls a) Walgreens Lansoprazole Delayed Release Capsules, USP 15 mg/Acid Reducer, 14 capsules per Bottle, Dist by Walgreen Com
Hazard: Microbial Contamination of Non-Sterile Products: Out-of-specification results for microbial count were observed at the initial stability interval for Lansoprazole Delayed Release Capsules.
February 12, 2014DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Dr. Reddy's Metoprolol Succinate Extended-Release Tablets USP, 50 mg 100 tablets Rx Only Mfd. By: Dr. Reddy's Laboratori
Hazard: Failed Dissolution Specification; 12-Month stability interval.
September 25, 2013DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls IBU (TM) IBUPROFEN Tablets, USP, 800 mg, 500 -count bottle,(NDC 55111-684-05) Rx only, Distributed by Dr. Reddy's Labora
Hazard: Labeling: Incorrect or missing lot and/or exp date- This product is being recalled due to an incorrect expiration date of 05/2017. The correct expiration date is 10/2016.
August 21, 2013DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Ranitidine Hydrochloride Tablets, USP, 150 mg, OTC, a) Equate brand Maximum Strength Acid Reducer, 65 count bottle Dist
Hazard: Microbial Contamination of Non-Sterile Products: A lot of raw material used in the manufacture of Ranitidine was positive for Pseudomonas sp.
April 10, 2013DrugsFDA
Dr. Reddy'S Laboratories recalls Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepal
Hazard: Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.
March 6, 2013DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Citalopram tablets USP, 40mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, I
Hazard: Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
March 6, 2013DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Citalopram tablets USP, 20mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, I
Hazard: Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
March 6, 2013DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Citalopram tablets USP, 10mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli,
Hazard: Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
November 28, 2012DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Dr. Reddy's Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets. Mfd By: Dr. Reddy's Laboratories Limited, Bachep
Hazard: Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.
August 8, 2012DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Dr. Reddy's Ciprofloxacin Tablets, USP 500 mg*, 500 Tablets, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepa
Hazard: Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets
August 8, 2012DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Dr. Reddy's Amlodipine Besylate and Benazepril Hydrochloride 5 mg*/20 mg, 500 Capsules, Rx only, Mfd. By: Dr. Reddy's L
Hazard: Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets.